You have 9 free searches left this month | for more free features.

gs-5829

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Estrogen Receptor Positive HER2- Breast Cancer Trial in United States (GS-5829, Exemestane, Fulvestrant)

Terminated
  • Advanced Estrogen Receptor Positive HER2- Breast Cancer
  • GS-5829
  • +2 more
  • Stanford, California
  • +5 more
Jul 15, 2019